Aldeyra Therapeutics (NASDAQ:ALDX) Stock Rating Upgraded by StockNews.com : vimarsana.com

StockNews.com upgraded shares of Aldeyra Therapeutics (NASDAQ:ALDX – Free Report) from a sell rating to a hold rating in a research report released on Tuesday morning. Several other equities analysts have also commented on the company. HC Wainwright reiterated a buy rating and issued a $10.00 target price on shares of Aldeyra Therapeutics in a […]

Related Keywords

Los Angeles , California , United States , Bruce Greenberg , Securities Exchange Commission , Jacobs Levy Equity Management Inc , Acadian Asset Management , Aldeyra Therapeutics Company Profile , Perceptive Advisors Llc , Los Angeles Capital Management , International Assets Investment Management , Aldeyra Therapeutics , Free Report , Therapeutics Trading Down , Get Free Report , Exchange Commission , Angeles Capital Management , Asset Management , Levy Equity Management , Assets Investment Management , Laurion Capital Management , Capital Management , Scavenger Receptor , Aldeyra Therapeutics Daily , Nasdaq Aldx , Aldx , Medical , Upgrade , Stocknews Com ,